Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Double-blind Phase	STARTED	DB MA-CS 550 mg/Day	2
Double-blind Phase	STARTED	DB MA-CS 300 mg/Day	0
Double-blind Phase	STARTED	DB Placebo	2
Double-blind Phase	STARTED	OL MA-CS 550 mg/Day	0
Double-blind Phase	COMPLETED	DB MA-CS 550 mg/Day	0
Double-blind Phase	COMPLETED	DB MA-CS 300 mg/Day	0
Double-blind Phase	COMPLETED	DB Placebo	1
Double-blind Phase	COMPLETED	OL MA-CS 550 mg/Day	0
Double-blind Phase	NOT COMPLETED	DB MA-CS 550 mg/Day	2
Double-blind Phase	NOT COMPLETED	DB MA-CS 300 mg/Day	0
Double-blind Phase	NOT COMPLETED	DB Placebo	1
Double-blind Phase	NOT COMPLETED	OL MA-CS 550 mg/Day	0
Extension Phase	STARTED	DB MA-CS 550 mg/Day	0
Extension Phase	STARTED	DB MA-CS 300 mg/Day	0
Extension Phase	STARTED	DB Placebo	0
Extension Phase	STARTED	OL MA-CS 550 mg/Day	1
Extension Phase	COMPLETED	DB MA-CS 550 mg/Day	0
Extension Phase	COMPLETED	DB MA-CS 300 mg/Day	0
Extension Phase	COMPLETED	DB Placebo	0
Extension Phase	COMPLETED	OL MA-CS 550 mg/Day	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00637806/flow